MetaCap

Kewaunee Scientific Earnings

NASDAQ: KEQUIndustrialsMedical SpecialitiesUSD

32.19-0.99 (-2.98%)

At close: Oct 15, 4:00 PM ET · Delayed 15 min

Kewaunee Scientific earnings summary

In its most recent report on Sep 9, 2026 (Q1 2027), KEQU posted EPS of $0.58. Revenue for the quarter was $66.3 million. Quarterly EPS is down 44.2% from the same quarter a year earlier.

Across the last 16 reports, KEQU shares moved an average of 3.2% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.

Summary generated from market data by MetaCap's automated system. Methodology

KEQU earnings history

Kewaunee Scientific reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Sep 9, 2026—$0.58—-1.0%
Jun 23, 2026—$1.13—+2.4%
Mar 11, 2026—$0.23—-3.2%
Dec 10, 2025—$0.82—+1.3%
Sep 10, 2025—$1.04—+3.8%
Jun 26, 2025—$1.63—+3.9%
Mar 12, 2025—$0.45—-2.3%
Dec 11, 2024—$1.01—+0.9%
Sep 11, 2024—$0.74—-3.9%
Jun 26, 2024—$3.74—-5.5%
Mar 6, 2024—$0.85—+8.5%
Dec 6, 2023—$0.93—+5.4%
Sep 1, 2023—$0.86—+1.5%
Jun 30, 2023—$0.36—+0.4%
Mar 10, 2023—$0.25—-2.4%
Dec 9, 2022—$-0.09—-4.1%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related